MEGHAN FERRELL: Open Payments
NPI 1518555630 · ZANESVILLE, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,699 in 81 payments from 16 companies in 2025. Trend: 2023 $1,661 · 2024 $1,351 · 2025 $1,699
Food & beverage: $1,699
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 20 | $541 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $186 |
| Alkermes, Inc. | 11 | $180 |
| Janssen Pharmaceuticals, Inc | 9 | $167 |
| Alpha Cognition USA, Inc. | 2 | $103 |
| Otsuka America Pharmaceutical, Inc. | 5 | $102 |
| Axsome Therapeutics, Inc. | 3 | $63 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $56 |
| Neurocrine BioSciences, Inc. | 3 | $56 |
| Teva Pharmaceuticals USA, Inc. | 3 | $48 |
Products named: COBENFY, CAPLYTA, ARISTADA, SPRAVATO, Zunveyl, REXULTI, Auvelity, TRINTELLIX.
Industry payments across OH — which companies pay providers there.
